Monsheel Sodhi
 |
Monsheel Sodhi, MRPharmS, PhD Assistant Professor,Department of Pharmacy Practice | |
| mssodhi@uic.edu | ||
| Phone | 312-355-5949 | |
| Fax | 312-413-9303 | |
| Office | 3102 MBRB | |
| US Mail | 900 South Ashland, Room 3102 MBRB MC870, Chicago, IL 60612 | |
| Research Interests Dr. Sodhi's areas of interest include the contribution of genetic, epigenetic, and post-transcriptional variation to the etiologies of major psychiatric disorders and suicide; and the pharmacogenetics of schizophrenia and mood disorders. Education |
| Bachelor of Pharmacy, University of London, London, United Kingdom |
| Master of Science in Neuroscience, University of London, London, United Kingdom |
| PhD in Genetics, Institute of Psychiatry, University of London, London, United Kingdom |
| Postdoctoral training completed at the University of Oxford, United Kingdom and the Department of Pharmacology at Vanderbilt University |
| Current UIC Appointments |
| Assistant Professor, Department of Pharmacy Practice |
| Representative Publications |
- SODHI MS, SIMMONS M, MCCULLUMSMITH R, HAROUTUNIAN V, MEADOR-WOODRUFF JH (2011). Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia. Biol Psychiatry. [Epub ahead of print]
- SIMMONS M, MEADOR-WOODRUFF JH, SODHI MS (2010). Increased cortical expression of an RNA editing enzyme occurs in major depressive suicide victims. Neuroreport 21(15):993-7.
- ROTH TL, LUBIN FD, SODHI M, KLEINMAN JE (2009). Epigenetic mechanisms in schizophrenia. Biochim Biophys Acta. 1790(9):869-77.
- SODHI M, WOOD KH, MEADOR-WOODRUFF J (2008). Role of glutamate in schizophrenia: integrating excitatory avenues of research. Expert Rev Neurother. 8(9):1389-406
- SODHI MS, AIREY DC, LAMBERT W, BURNET PW, HARRISON PJ, SANDERS-BUSH E (2005). A rapid new assay to detect RNA editing reveals antipsychotic-induced changes in serotonin-2C transcripts. Mol Pharmacol. 68(3):711-9.
- SODHI MS, SANDERS-BUSH E (2004). Serotonin and brain development. Int Rev Neurobiol. 2004;59:111-74.
- TUNBRIDGE, E., P. W. BURNET, SODHI MS, HARRISON PJ (2004). "Catechol-o-methyltransferase(COMT) and proline dehydrogenase (PRODH) mRNAs in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression." Synapse 51(2):112-8.
- SODHI MS, BURNET PJ, MAKOFF AJ and HARRISON PJ.(2001): Reduced mRNA editing of the human 5-HT2C receptor in schizophrenia. Molecular Psychiatry, 6 (4), 373-9.
- ARRANZ MJ, MUNRO J, BIRKETT J, BOLONNA A, MANCAMA D, SODHI MS, et al. (2000): Pharmacogenetic prediction of clozapine response. Lancet 355: 1615 - 1616.
- ARRANZ MJ, ERDMANN J, KIROV G, RIETSCHEL M, SODHI M, et al (1997). 5-HT2A receptor and bipolar affective disorder: Association studies in affected patients. Neurosci Lett 224 (2): 95-98.
- COLLIER D, ARRANZ M, SHAM P, BATTERSBY S, GILL P, AITCHISON KJ, SODHI MS, et al. (1996):The serotonin transporter is a potential susceptibility factor for bipolar affective disorder. NeuroReport7:1675-1679.
- ARRANZ MJ, COLLIER DA, MUNRO J, SHAM P, KIROV G, SODHI MS, ROBERTS GW, PRICE J, AND KERWIN RW (1996): Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217:177-178.
- SODHI MS, ARRANZ MJ, CURTIS DA, SHAM PC, BALL DM, ROBERTS GW, PRICE J, COLLIER DA AND KERWIN RW (1995): Association between clozapine response and allelic variation in the 5- HT2C receptor gene. NeuroReport 7: 369-375.
- ARRANZ MJ, COLLIER D, SODHI MS, BALL DM, ROBERTS GW, PRICE J, SHAM P AND KERWIN R.1995): Association between clozapine response and allelic variation in the 5-HT2A receptor gene. Lancet, 346: 281-282.
Click here to view Dr. Sodhi's on-line CV. 
For more information about the Sodhi laboratory, please click here